Journal de recherche et de thérapie sur les cellules souches

Abstrait

Melatonin Induces Neuroprotection via System Xc Regulation in Neural Stem Cells

Melinda Clarke, Stephanie Crockett and Brian Sims

Hypoxic-brain injury is a major cause of neonatal morbidity and mortality. However, melatonin (N-acetyl-5- methoxytryptamine) has been identified as an indirect anti-oxidant and direct free radical scavenger that could possibly reduce the injurious effects of hypoxic-ischemic brain injury in neonatal infants. Hypoxia-ischemia leads to multiple consequences such as an increase in extracellular glutamate. Yet the many mechanisms involved in melatonin-induced neuroprotection are still under investigation. We have hypothesized that melatonin could induce neuroprotection by increasing levels of cystine glutamate exchanger (xCT), an amino acid transporter as shown in previous work in our laboratory. Mouse neural stem cells were used for all in vitro studies for western blot analysis. In dose-response studies, melatonin increases xCT expression by 2.43 ± 0.81, 3.58 ± 0.6, 3.21 ± 1.13, 3.30 ± 0.96 and 3.48 ± 0.30 (p < 0.01) folds at 1 nM, 10 nM, 100 nM, 1 µM and 10 µM concentrations respectively in neural stem cells. In time-course studies, melatonin increases xCT by 2.60 ± 0.97, 2.65 ± 0.27, 3.29 ± 0.40, and 3.57 ± 0.60 fold at 4 hours, 8 hours, 12 hours, and 24 hours. Melatonin increases cystine uptake. System Xc inhibition decreased cell viability. These results suggest that melatonin may induce neuroprotection by increasing xCT expression and activity.